Efficacy and safety of xuezhikang once per day versus two times per day in patients with mild to moderate hypercholesterolaemia (APEX study): a protocol for a multicentre, prospective randomised controlled, open-label, non-inferiority study

INTRODUCTION: Reduction in low-density lipoprotein cholesterol (LDL-C) improves clinical outcomes in patients with coronary artery disease. However, rates of lipid-lowering medication adherence are far from ideal. Reducing dosage frequency from multiple dosing to once-daily dosing may improve patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Zexuan, Wu, Dexi, Jiang, Jingzhou, Chen, Ailan, Zheng, Dong-Dan, Li, Jianhao, Dong, Yugang, Chen, Yili
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239523/
https://www.ncbi.nlm.nih.gov/pubmed/32423930
http://dx.doi.org/10.1136/bmjopen-2019-034585

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239523/
https://www.ncbi.nlm.nih.gov/pubmed/32423930
http://dx.doi.org/10.1136/bmjopen-2019-034585

Ejemplares similares